• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Application and prospect of adipose stem cell transplantation in treating lymphedema

    2020-08-10 01:51:48ZhuJunLiElanYangYunZhuLiZhengYunLiangJiuZuoHuangNanZeYuXiaoLong
    World Journal of Stem Cells 2020年7期

    Zhu-Jun Li, Elan Yang, Yun-Zhu Li, Zheng-Yun Liang, Jiu-Zuo Huang, Nan-Ze Yu, Xiao Long

    Zhu-Jun Li, Elan Yang, Yun-Zhu Li, Zheng-Yun Liang, Jiu-Zuo Huang, Nan-Ze Yu, Xiao Long, Department of Plastic and Reconstructive Surgery, Peking Union Medical College Hospital of Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100730, China

    Abstract

    Key words: Lymphedema; Adipose-derived stem cells; Animal model; Clinical trial; Vascular endothelial growth factor-C; Lymphangiogenesis

    INTRODUCTION

    As the second circulatory system of the body, the lymphatic system functions to transport tissue fluid in the interstitial space back to the venous circulation system and maintain fluid homeostasis.Hypoplasia or dysfunction of lymphatic vasculature may result in “l(fā)ymphedema”[1], which is characterized by retention of lymphatic fluid in the interstitial space, leading to a series of pathological changes, including tissue swelling, chronic inflammation, lipid deposition, and tissue fibrosis[2].

    There are two types of lymphedema according to etiology[3].Primary lymphedema comes from developmental or congenital abnormalities of the lymphatic system resulting in dysfunctional lymphatics, which could be symptomatic at birth or more commonly in adolescence.Secondary lymphedema is more common and results from trauma, obstruction, surgery, or infection involving the lymphatic system.Up to 250 million people in developing countries suffer from lymphedema, with the parasitic disease filariasis as the most prevalent cause[4]; lymphadenectomy and radiation therapy for cancer treatment are usually the major causes of lymphedema in developed countries.

    Chronic lymphedema affects 0.13%-2% of the global population[5].It is estimated that one out of six patients undergoing treatment for a solid tumor will eventually develop lymphedema[6].For patients with breast cancer, 24%-49% of those receiving mastectomy will develop upper extremity lymphedema[7].The persistence of the disease, burden of treatment, and likelihood of progression press heavy medical and socioeconomic burdens onto patients.Therefore, development of effective therapies for lymphedema is of vital importance.

    Lymphedema can be treated conservatively, surgically, or by a combination of them[2].Conservative therapies consist of complex decongestive therapy, manual lymphatic drainage, and exercise[8].Surgical therapies include liposuction, wedge resection, Charles procedure (radical excision for limb lymphedema), and lymphatic reconstruction or bypass techniques[9].However, there is a lack of effective and feasible therapies which could radically cure lymphedema[10].Therefore, elucidating the underlying pathophysiological mechanisms of lymphedema holds promise for the treatment of lymphedema.

    Progenitor or stem cell-based therapies, which treat diseases through regeneration, have represented an alternative treatment method not only for lymphedema but for a wide spectrum of other diseases as well.Due to their abundant resources, easy access, pluripotent capacity, and harboring of few ethical and immunological issues, the adipose-derived stem cells (ADSCs) are considered as one of the most promising seed cell types for regenerative medicine[11-15].In addition, ADSCs exhibit paracrine immunomodulatory and trophic effects in their local microenvironment.Emergingin vitrostudies have investigated the possible mechanisms and benefit of ADSCs in the treatment of lymphedema, such as their capacity for differentiation into lymphatic endothelial cells (LECs)[16,17]and paracrine secretion of cytokines[18], chemokines[19]and exosomes[20], thereby promoting angiogenesis and modulating the immune response.Takedaet al[21]reported that, by secreting lymphangiogenic factors, ADSCs promote proliferation, migration, and tube formation of LECsin vitro.Denget al[22]demonstrated that overexpression of Prox1 in human ADSCs (vialentiviral vectors) induces the differentiation of human ADSCs into stable lymphatic endothelial-like cellsin vitroand that the differentiated cells form tube-like structures (as shown in tube formation assay).Yenet al[23]showed that ADSCs promote lymphangiogenesis under stimulation of vascular endothelial growth factor-C (VEGF-C), a key lymphangiogenic factor, or in response to inhibition of TGF-β1; moreover, stimulation of ADSCs with VEGF-C was found to markedly increase cellular proliferation and cellular survival afterin vivoimplantation and to induce the expression of podoplanin, a lymphangiogenic cell marker.Sunet al[19]reported that interleukin-7 enhanced the differentiation of ADSCs into LECsviaAKT signaling pathways.Most recently, Saijoet al[24]revealed that paracrine effects of ADSCs promoted lymphangiogenesis in irradiated LECs.They reported that coculture with ADSCs and the use of ADSCconditioned medium improved proliferation, migration, and tube formation of nonirradiated LECs.Furthermore, they demonstrated that irradiated ADSCs can exert similar alleviative effects to irradiated human dermal LECs[24].

    Collectively, these research findings have suggested that ADSCs might serve as suitable seed cells for lymphatic tissue engineering and secondary lymphedema therapy.The aim of this review is to systematically summarize the application of ADSCs for lymphedema treatment in animal studies and in clinical trials.In addition, the future perspectives of ADSCs in lymphedema therapy are discussed.

    MATERIALS AND METHODS

    A systematic search was performed on four databases (PubMed, Clinicaltrials.gov, the evidence-based Cochrane library, and OVID) using the following search string: (“l(fā)ymphedema” or “l(fā)ymphoedema” or “l(fā)ymphangiogenesis”) and (“adipose-derived stem cells” or “adipose-derived stromal cells” or “adipose-derived regenerative cells”).After duplicate removal, all studies were screened based on title and abstract.Furthermore, full-text versions of included studies were read for further evaluation.A manual search was also performed by skimming the references of included studies.The search process is presented in Figure 1.

    The inclusion criteria were animal studies and clinical trials using adipose-derived cells for treatment of any kind of lymphedema, which had been published no later than November 2019.The exclusion criteria were non-English language, reviews, orin vitrostudies.For animal studies, data retrieved were year of publication, first author, type of animal models, cell type used (freshly isolated or culture-expanded as well as autologous or allogeneic), cell dosage, cell characterization (cell count/viability, surface marker analysis,etc.), means and routes of transplantation (alone or in combination with growth factors, scaffolds,etc.), assessment types, and results.For clinical trials, data retrieved were year of publication, country of origin, disease treated, study design (randomized controlled trial, nonrandomized study, or case series/pilot study), number of participants, cell type used (freshly isolated or cultureexpanded as well as autologous or allogeneic), cell dosage, cell characterization (cell count/viability, surface marker analysis,etc.), means and routes of transplantation (alone or in combination with growth factors, scaffolds,etc.), assessment types, and outcomes.

    Figure 1 Search process of articles regarding adipose-derived stem cell-based treatment of lymphedema studied in animal models and clinical trials.

    RESULTS

    A total of eight research articles published before November 2019 met the inclusion criteria for this analysis.These included five articles focused on animal studies (Table 1) and three focused on clinical trials (Table 2).

    Animal studies

    A total of five animal studies were included in the analysis.Commonly-used animal models were mouse hindlimb or tail model of lymphedema.The surgical procedures were circumferential incision with or without radiation.The number of cells used for injection varied from 104to 1010each time.Various treatments were used in combination with cell injection, including controlled-release VEGF-C, platelet-rich plasma (PRP), or vascularized lymph node transfer.Treatment outcomes were evaluated by circumference, dermal edema depth, imaging (lymphangiography and photodynamic dye), and histochemical and immunohistochemical staining (for CD31, LYVE1, and VEGF receptor).

    Hwanget al[25]established a mouse hindlimb model of lymphedema by electrocauterizing the lymph vessels in the thigh following a circumferential incision.In vivostudy demonstrated that combination of human (h) ADSCs and VEGF-C hydrogel markedly alleviated dermal edema and increased lymphatic vessel density when compared with results achieved with hADSCs or VEGF-C hydrogel alone at various post-treatment time points (from 3-4 d to 4 wk post-treatment).In addition, the authors demonstrated the existence of hADSCs in all of the implantation sites in the hADSC/VEGF-C group with LECs phenotype.Their results also suggested that, in conjunction with hADSCs, VEGF-C-containing hydrogels could serve as suitable delivery vectors to improve lymphangiogenesis.

    Shimizuet al[26]reported on the establishment of a mouse tail model of lymphedema.They made a 2 mm-wide circumferential excision on the skin 10 mm distal to the tail base and excluded a 4 mm2dermal flap at the ventral side.They indicated that local injection of 2 × 106freshly isolated autologous ADSCs could reduce lymphedema and accelerate lymphangiogenesis at the congestive lymphedema region.The authors also revealed that ADSCs could release VEGF-C to stimulate lymphangiogenesis and recruit bone marrow-derived M2 macrophages to serve as lymphatic endothelial progenitor cells.

    Ackermannet al[27]assessed the effects of PRP and adipose stem cells on angiogenesis, microcirculation, lymphangiogenesis, microvascular architecture, and wound healing in a mouse tail lymphedema model.They found that treatment with PRP and adipose stem cells could accelerate wound healing and increase epithelialization.PRP application induced a remarkably improved lymphangiogenesis.Ultimately, the authors drew the conclusion that PRP and adipose stem cells can affect lymphangiogenesis and lymphedema development.

    Table 1 Adipose-derived stem cell-based treatment of lymphedema in animal studies

    ADRCs: Adipose-derived regenerative cells; ADSCs: Adipose-derived stem cells; ASC: Adipose stem cells; EGFP: Enhanced green fluorescent protein; FISH: Fluorescent in situ hybridization; H&E: Hematoxylin and eosin; hADSCs: Human adipose-derived stem cells; IFC: Immunofluorescence; IHC: Immunohistochemistry; N/A: Not applicable; PBS: Phosphate-buffered saline; VEGF-C: Vascular endothelial growth factor-C; VEGF-R3: Vascular endothelial growth factorreceptor 3; VLNT: Vascularized lymph node transfer.

    Yoshida et al[28]reported on the establishment of a mouse right hindlimb secondary lymphedema model, using 30 Gy X-ray irradiation 7 d before surgery to create a circumferential incision and a gap of approximately 2 mm, left open.Circumferential measurement, lymphatic flow assessment, and quantification of lymphatic vessels demonstrated that at 14 d post-treatment of local injection with 106ADSCs, 105ADSCs, or 104ADSCs, the numbers of lymphatic vessels were significantly increased in the transplanted groups; the authors concluded that in secondary lymphedema, ADSCs could increase collecting vessels and reconstruct the lymphatic vascular network.A more recent study from the same research group[29]demonstrated that local implantation of 104ADSCs in combination with vascularized lymph node transfer decreased tissue volume, increased lymphatic vessels density, and improved the lymphatic function in a slightly different mouse hindlimb model (left vs right hindlimb, 5 mm- vs 2 mm-wide gap, left open).

    Clinical trials

    A total of three clinical trials were included in the analysis.All these studies were conducted by the same research group in Denmark[25-27], focusing on upper limb and breast cancer-related lymphedema (BCRL), using freshly isolated autologous ADSCs with fat grafting.The follow-up period ranged from 4 mo to 1 year.

    Table 2 Adipose-derived stem cell treatment of lymphedema in clinical trials

    In 2016, Toyserkaniet al[30]reported a pilot study using ADSC-assisted lipotransfer to treat lymphedema.A 48-year-old female patient developed BCRL after lymphadenectomy and radiation therapy.A total of 4.07 × 107freshly isolated autologous ADSCs were administered, along with 10 mL of lipoaspirate (for fatgrafting), to the axillary region.At 4 mo post-treatment, the authors noted that the daily symptoms of arm heaviness and tension were greatly relieved, the needs for compression therapy were reduced, and the volume of the affected arm was decreased without postoperative complications or adverse events.

    Furthermore, the authors had also performed a larger study to validate the feasibility and safety of this procedure in 2007[31], which was registered at Clinicaltrials.gov under the identifier NCT02592213 at phase 2 stage.In this pilot study, ten BCRL patients were included.Combined with a scar-releasing fat graft (about 30 mL) procedure, approximately 5 × 107freshly isolated adipose-derived regenerative cells (ADRCs) were injected into the axillary region.During a 6-mo follow-up period, there was a small but not significant volume reduction.Five of the patients showed a reduced need for conservative treatment, and patient-reported follows-up improved significantly over time.Slight, temporary adverse events were observed, but were more likely caused by liposuction procedures rather than ADRC injection.Ultimately, the ADRCs were deemed as well-tolerated.

    In 2019, the results of lymphoscintigraphic evaluation with 1-year follow-up were reported[32].Consistent with the results of the 6-mo follow-up, ADRC injection improved lymphedema, as revealed by patient-reported outcomes without serious adverse events.However, there was no improvement in lymphoscintigraphic evaluation and no change in arm volume after the ADRC treatment.Now, this research group is recruiting patients for a randomized phase 3 trial, which is registered at Clinicaltrials.gov under the identifier NCT03776721.This study started December 17, 2018 and the estimated study completion date is September 1, 2021, designed to recruit 80 participants with a parallel assignment to evaluate the efficacy and safety of implantation of freshly isolated adipose-derived stromal cells in combination with fat grafting at the affected axillary region.

    DISCUSSION

    Lymphedema, characterized by tissue swelling, lipid deposition, and fibrosis due to excess accumulation of interstitial fluid and inadequate lymphatic drainage, affects 0.13%-2% of the global population[5]and remains a chronic, debilitating and incurable disease.Stem cell-based regenerative medicine has shown great promise for refractory diseases, such as inflammatory bowel diseases[33], heart failure[34], osteoarthritis[35], rheumatoid arthritis[36], and graft-versus-host disease[37].With the properties of selfrenewal, multipotential differentiation, paracrine, immunomodulatory, and trophic effects, and low immunogenicity alongside their practical advantages, ADSCs have become one of the most promising candidates for regenerative medicine.

    ADSCs are isolated from the aqueous fraction – known as the stromal vascular fraction (SVF) – by means of enzymatic digestion of lipoaspirate (liposuction product)[38,39].As the major source of ADSCs, SVF is a heterogeneous cell group composed of ADSCs, endothelial precursor cells, endothelial cells, macrophages, smooth muscle cells, lymphocytes, pericytes, and pre-adipocytes derived from fat tissue.Recent advances have shown the role and efficacy of SVF and ADSCs in improvement of tissue regeneration, especially in plastic reconstruction[40], such as breast reconstruction[41,42], wound healing[43,44], scars[45,46], and soft tissue defects[47].The SVF is more easily obtained, regardless of cell separation and culture conditions.Therefore, therapeutic cellular products are obtained immediately with minimal contact with reagents, making it not only technically easier but also relatively safer.At the same time, the unique heterogeneous cell components of SVF may achieve better treatment results in comparative animal studies.It is worth noting that SVF might be suitable for autologous therapy only, due to the existence of various cell types that might cause immunological rejection[48], whereas ADSCs are useful in both allogenic therapy and autologous therapy.

    As mentioned in the first part of this review, emergingin vitrostudies have already definitively demonstrated the advantage of ADSCs in lymphangiogenesis and treatment of lymphedema.All five animal studies included in this systematic review were performed on mouse models and the ADSCs were injected immediately or shortly after lymphedema induction.These studies examined the effect of ADSCs on acute lymphedema and exhibited improvement at 4-6 wk.However, the anatomy, physiology, and healing capacity are quite different between mice and human beings, bringing up the need for larger animal models in order to simulate chronic lymphedema in human beings more accurately.Further preclinical studies with better animal models are needed to determine whether ADSC-based therapies could fulfil expectations and be extrapolated to clinical use in patients.As is commonly known, to observe lymphatics in mice, it is usually necessary to visualize the blue dye-stained lymphatic vessels in dissected tissues or tissue sectioning for immunohistological staining for the lymphatic markers, such as VEGFR-3, PROX1, and LYVE1, to quantitatively identify lymphatic vessel intensity and lymphangiogenesis.Advances in near-infrared fluoroscopy lymphatic imaging[49], magnetic resonance imaging agents based on nanotechnology, and gene reporter technologies have paved roads for depicting functions of lymphatic vasculature.Though not all lymphatic imaging methods are suitable for both clinical and preclinical trials, their effective combination will provide new tools for lymphedema translational medicine[50].

    Therapy of lymphedema has benefitted substantially from the most recent advances in lymphatic vessel engineering and regenerative medicine, including cell-seeded scaffolds for vessel reconstruction, implantation of stem cells, prolymphangiogenic growth factors, or a combination of these technologies.As mentioned above, when implanted into the injury site in a lymphedema mouse model, the gelatin hydrogel containing controlled-release VEGF-C could encapsulate hADSCs, increase vessel density, and improve dermal edema, leading to efficient application in lymphatic vessel regeneration[25].It has been reported that SVFs and ADSCs could improve wound healing when used alone or in combination with PRP and hyaluronic acid, specifically in healing of lower-extremity soft- and hard-tissue wounds[43]and in severe hidradenitis suppurativa wounds[47].Many other studies confirmed that SVFs and ADSCs can improve wound healing when used alone or in combination with PRP and fat graft[41,45,51,52].Considering the similar biological processes and biomolecular pathways shared between wound healing and lymphedema, such as inflammation and angiogenesis, the efforts towards establishing ADSCs-based therapy for lymphedema will benefit from these studies.Certainly, the research efforts towards development of cell isolation and expansion methods and of three-dimensional scaffolds[53], nanoparticles, and targeted delivery will help to optimize and maximize the efficacy of ADSC-assisted therapy.Standardized platforms with minimized manipulations and maximized efficacy will facilitate both up-scaling and the ease of clinical translation.

    Over the past few years, concerns regarding the safety of stem cell application have also been raised.Indeed, Toyserkaniet al[54]performed a systematic review, including over 1400 patients who received ADSC treatment and were followed for 4 wk to 3 years, in order to assess the safety of ADSC therapy, concentrating on the risks of thromboembolical, immunological, and oncological safety concerns.They reported that the observed adverse outcomes were relevant to liposuction, injuries from implantation, or the underlying condition, rather than the ADSC therapy itself.Although the ADSC therapy has shown a favorable safety performance, more reliable and rigorous safety assessment approaches are still encouraged for further study and clinical practice.

    In conclusion, the results ofin vitrostudies, animal models, and clinical trials characterize ADSC-based treatment as a promising option and one that can be used within biologically rational and controllable environments for the treatment of lymphedema.However, further investigations in larger animal models and largerscale, multicenter randomized clinical trials with more reliable and rigorous safety assessments are needed to develop more effective and durable therapeutic strategies.

    ARTICLE HIGHLIGHTS

    Research background

    Lymphedema is a chronic, debilitating and incurable disease that affects 0.13%-2% of the global population.Emerging evidence indicates that adipose-derived stem cells(ADSCs) might serve as suitable seed cells for lymphatic tissue engineering and lymphedema therapy.Here, we appraise the in vivo evidence for the application of ADSCs for lymphedema treatments.

    Research motivation

    Emerging research findings have suggested that ADSCs might serve as suitable seed cells for tissue engineering of lymphatic vessels in vitro and potentially in the treatment of secondary lymphedema in vivo.It is critical that we systematically summarize the application of ADSCs for lymphedema treatments in animal studies and in clinical trials and discuss the future perspectives.

    Research objectives

    The main objectives of this review are to systematically summarize the application of ADSCs for lymphedema treatments as shown in animal studies and clinical trials.In addition, the future perspectives of ADSCs in lymphedema therapy are discussed.

    Research methods

    A systematic search was performed on four databases – PubMed, Clinicaltrials.gov, the evidence-based Cochrane library, and OVID – using the following search string: (“l(fā)ymphedema” or “l(fā)ymphoedema” or “l(fā)ymphangiogenesis”) and (“adipose-derived stem cells” or “adipose-derived stromal cells” or “adipose-derived regenerative cells”).A manual search was performed by skimming the references of relevant studies.Animal studies and clinical trials using adipose-derived cells for the treatment of any kind of lymphedema were included.

    Research results

    A total of eight research articles published before November 2019 were included for this analysis.Five articles focused on animal studies and another three focused on clinical trials.ADSC transplantation therapy was demonstrated to be effective against lymphedema in all studies.The animal studies found that coadministration of ADSCs and controlled-release vascular endothelial growth factor-C or platelet-rich plasma could improve the effectiveness of ADSC therapy.Three sequential clinical trials were conducted on breast cancer-related lymphedema patients, and all showed favorable results.

    Research conclusions

    The results ofin vitrostudies, animal models, and clinical trials characterize ADSCbased treatment as a promising option and one that can be used within biologically rational and controllable environments for the treatment of lymphedema.

    Research perspectives

    Further preclinical studies in larger animal models and large-scale, multicenter randomized controlled clinical trials with more reliable and rigorous safety assessments are needed to develop more effective and durable therapeutic strategies.Advances in lymphatic imaging methods will provide opportunities for lymphedema translational medicine as well.

    久久这里只有精品中国| 亚洲电影在线观看av| 动漫黄色视频在线观看| 国产免费av片在线观看野外av| 天天添夜夜摸| 三级毛片av免费| 亚洲在线自拍视频| 999久久久精品免费观看国产| av国产免费在线观看| 90打野战视频偷拍视频| av福利片在线| 久久热在线av| 妹子高潮喷水视频| 国产精品一区二区三区四区久久| 欧美成狂野欧美在线观看| 日本三级黄在线观看| 搞女人的毛片| 99re在线观看精品视频| 日日干狠狠操夜夜爽| 99久久精品国产亚洲精品| 成人欧美大片| 免费在线观看影片大全网站| 99精品欧美一区二区三区四区| 一级片免费观看大全| 久久久国产成人免费| 欧美大码av| 少妇熟女aⅴ在线视频| 久久久久亚洲av毛片大全| 美女高潮喷水抽搐中文字幕| 午夜精品在线福利| 国产探花在线观看一区二区| 久久久久久免费高清国产稀缺| 99久久精品热视频| 欧美黑人巨大hd| 久久草成人影院| 久久精品国产综合久久久| 日韩免费av在线播放| 亚洲精品色激情综合| 中国美女看黄片| 美女扒开内裤让男人捅视频| 国产精品1区2区在线观看.| 国产成人系列免费观看| 国产成人精品无人区| 久久久国产成人精品二区| 午夜日韩欧美国产| 亚洲乱码一区二区免费版| 亚洲精品国产精品久久久不卡| 欧美乱妇无乱码| 亚洲天堂国产精品一区在线| 欧美三级亚洲精品| 久久精品影院6| 男插女下体视频免费在线播放| 国产精品 欧美亚洲| 曰老女人黄片| 国产欧美日韩一区二区三| 免费搜索国产男女视频| 欧美极品一区二区三区四区| 国产乱人伦免费视频| 亚洲国产看品久久| 成人午夜高清在线视频| 首页视频小说图片口味搜索| 亚洲一区中文字幕在线| 国产精品久久久久久精品电影| cao死你这个sao货| 国产成人啪精品午夜网站| 国内精品一区二区在线观看| 国产精品久久久人人做人人爽| 亚洲国产精品成人综合色| 免费在线观看亚洲国产| 亚洲最大成人中文| 亚洲片人在线观看| 午夜免费激情av| 91大片在线观看| av福利片在线观看| 深夜精品福利| 亚洲人与动物交配视频| 欧美日韩国产亚洲二区| 国产又色又爽无遮挡免费看| а√天堂www在线а√下载| 性欧美人与动物交配| 国产午夜精品论理片| 亚洲精品一区av在线观看| 最近视频中文字幕2019在线8| 无人区码免费观看不卡| 搞女人的毛片| 他把我摸到了高潮在线观看| 国产欧美日韩一区二区精品| 日日爽夜夜爽网站| 亚洲美女黄片视频| 亚洲黑人精品在线| 国产单亲对白刺激| 国产精品免费视频内射| 亚洲精品美女久久久久99蜜臀| 日本一二三区视频观看| 一区二区三区国产精品乱码| 午夜免费成人在线视频| 国产精品久久久久久人妻精品电影| 又爽又黄无遮挡网站| 国产免费男女视频| 他把我摸到了高潮在线观看| 91国产中文字幕| 久久人妻av系列| 国产亚洲精品一区二区www| 国产午夜福利久久久久久| 在线视频色国产色| 亚洲片人在线观看| 色综合亚洲欧美另类图片| 日韩国内少妇激情av| 日日爽夜夜爽网站| 777久久人妻少妇嫩草av网站| 午夜福利在线在线| 久久久水蜜桃国产精品网| 国产亚洲欧美在线一区二区| av视频在线观看入口| 精品一区二区三区四区五区乱码| 狂野欧美激情性xxxx| 99热只有精品国产| 国产伦人伦偷精品视频| 久久久国产成人免费| √禁漫天堂资源中文www| 天堂av国产一区二区熟女人妻 | 人妻丰满熟妇av一区二区三区| 国产午夜精品论理片| 三级国产精品欧美在线观看 | 国产成人系列免费观看| 变态另类丝袜制服| 亚洲国产精品成人综合色| 国产成人aa在线观看| 国产亚洲欧美98| 午夜精品一区二区三区免费看| 国产熟女xx| 成人高潮视频无遮挡免费网站| 午夜两性在线视频| 婷婷精品国产亚洲av在线| 久久婷婷人人爽人人干人人爱| 欧美日韩中文字幕国产精品一区二区三区| 日韩av在线大香蕉| 日韩有码中文字幕| 亚洲欧洲精品一区二区精品久久久| 亚洲一区二区三区不卡视频| 久久久久久九九精品二区国产 | 可以在线观看的亚洲视频| 免费在线观看成人毛片| 国产精品永久免费网站| 欧美乱码精品一区二区三区| av福利片在线观看| 亚洲真实伦在线观看| 亚洲18禁久久av| 丝袜美腿诱惑在线| 精品免费久久久久久久清纯| 久99久视频精品免费| www国产在线视频色| 黄色a级毛片大全视频| 少妇熟女aⅴ在线视频| ponron亚洲| 欧美午夜高清在线| 亚洲精品中文字幕一二三四区| 女警被强在线播放| 久久人妻av系列| 不卡av一区二区三区| 白带黄色成豆腐渣| 神马国产精品三级电影在线观看 | 成人国语在线视频| 午夜日韩欧美国产| www.自偷自拍.com| 国产精品影院久久| 国产黄a三级三级三级人| a在线观看视频网站| 免费在线观看亚洲国产| 级片在线观看| 欧美日韩瑟瑟在线播放| 国产精品av视频在线免费观看| 18禁美女被吸乳视频| 色综合欧美亚洲国产小说| 搡老熟女国产l中国老女人| 成人av一区二区三区在线看| 午夜a级毛片| 精品乱码久久久久久99久播| 叶爱在线成人免费视频播放| 日韩高清综合在线| 精品欧美一区二区三区在线| 脱女人内裤的视频| 中文亚洲av片在线观看爽| 国产一区在线观看成人免费| 亚洲男人天堂网一区| 国产午夜精品久久久久久| 大型av网站在线播放| 日韩有码中文字幕| 久久久久久久久免费视频了| 变态另类成人亚洲欧美熟女| www.自偷自拍.com| 五月玫瑰六月丁香| 久久精品91无色码中文字幕| 国内精品久久久久久久电影| 法律面前人人平等表现在哪些方面| netflix在线观看网站| 好男人电影高清在线观看| 在线视频色国产色| or卡值多少钱| 在线观看日韩欧美| 最近最新中文字幕大全电影3| 中文资源天堂在线| 国产爱豆传媒在线观看 | 亚洲人成伊人成综合网2020| 欧美一区二区国产精品久久精品 | 国产亚洲精品久久久久5区| 99在线视频只有这里精品首页| 亚洲欧美精品综合久久99| 久久精品国产综合久久久| 丁香欧美五月| 亚洲黑人精品在线| 久久久精品国产亚洲av高清涩受| 好看av亚洲va欧美ⅴa在| 麻豆久久精品国产亚洲av| 女生性感内裤真人,穿戴方法视频| 亚洲一卡2卡3卡4卡5卡精品中文| 国产av麻豆久久久久久久| 亚洲精品在线观看二区| 免费看美女性在线毛片视频| av片东京热男人的天堂| 韩国av一区二区三区四区| 日本五十路高清| 琪琪午夜伦伦电影理论片6080| 三级毛片av免费| 99国产精品99久久久久| 亚洲中文字幕日韩| 亚洲av成人av| 免费在线观看黄色视频的| 精品第一国产精品| 亚洲成人中文字幕在线播放| 亚洲精品色激情综合| 久久午夜亚洲精品久久| 中文字幕高清在线视频| 国产一级毛片七仙女欲春2| 一进一出抽搐gif免费好疼| 男人舔奶头视频| 欧美日本亚洲视频在线播放| 美女免费视频网站| 我要搜黄色片| 两人在一起打扑克的视频| 国产探花在线观看一区二区| 欧美日本视频| 久久婷婷成人综合色麻豆| 九色成人免费人妻av| 嫁个100分男人电影在线观看| 久久热在线av| 97碰自拍视频| 一个人免费在线观看电影 | 亚洲一区高清亚洲精品| 久久久久国产精品人妻aⅴ院| 欧美午夜高清在线| 国产精品美女特级片免费视频播放器 | 亚洲自拍偷在线| 午夜福利在线观看吧| 国产又黄又爽又无遮挡在线| 成人国产综合亚洲| 欧美日本亚洲视频在线播放| 欧美成人性av电影在线观看| 午夜福利成人在线免费观看| 久久国产精品影院| 美女高潮喷水抽搐中文字幕| 给我免费播放毛片高清在线观看| 成年女人毛片免费观看观看9| 亚洲va日本ⅴa欧美va伊人久久| 亚洲自拍偷在线| 欧美成人性av电影在线观看| 欧洲精品卡2卡3卡4卡5卡区| 亚洲自偷自拍图片 自拍| www日本黄色视频网| 欧美在线一区亚洲| 熟女少妇亚洲综合色aaa.| 又紧又爽又黄一区二区| 久久香蕉国产精品| 在线看三级毛片| 国产午夜精品论理片| 精华霜和精华液先用哪个| 岛国在线免费视频观看| 中出人妻视频一区二区| 国产亚洲精品综合一区在线观看 | 夜夜爽天天搞| 91老司机精品| 两个人的视频大全免费| 亚洲精品粉嫩美女一区| 两性夫妻黄色片| 窝窝影院91人妻| 婷婷精品国产亚洲av在线| 香蕉丝袜av| 狂野欧美激情性xxxx| 欧美绝顶高潮抽搐喷水| 精品国产亚洲在线| 床上黄色一级片| aaaaa片日本免费| 免费一级毛片在线播放高清视频| 99久久久亚洲精品蜜臀av| 男女下面进入的视频免费午夜| 欧美一区二区国产精品久久精品 | 中文字幕高清在线视频| 日本免费一区二区三区高清不卡| 久久久国产精品麻豆| 国产高清有码在线观看视频 | 国产精品亚洲美女久久久| 婷婷精品国产亚洲av在线| 欧美日韩乱码在线| 久久久久久亚洲精品国产蜜桃av| 色老头精品视频在线观看| 国产欧美日韩一区二区三| 国产麻豆成人av免费视频| 久久精品国产综合久久久| 国产精品av视频在线免费观看| 国产熟女午夜一区二区三区| 亚洲专区字幕在线| 久久人人精品亚洲av| 两个人视频免费观看高清| 午夜久久久久精精品| 日本黄色视频三级网站网址| 久久久久久国产a免费观看| 可以免费在线观看a视频的电影网站| 亚洲色图av天堂| 哪里可以看免费的av片| x7x7x7水蜜桃| 又黄又粗又硬又大视频| 色综合亚洲欧美另类图片| 色播亚洲综合网| 日本三级黄在线观看| 亚洲成人免费电影在线观看| 亚洲精品美女久久久久99蜜臀| 中文字幕精品亚洲无线码一区| 亚洲成av人片在线播放无| 色在线成人网| 久久亚洲真实| 人妻丰满熟妇av一区二区三区| 亚洲av成人不卡在线观看播放网| 制服丝袜大香蕉在线| 校园春色视频在线观看| 麻豆成人av在线观看| 五月玫瑰六月丁香| 日本一区二区免费在线视频| 男男h啪啪无遮挡| 五月伊人婷婷丁香| 丝袜人妻中文字幕| 日日夜夜操网爽| 亚洲乱码一区二区免费版| 日韩av在线大香蕉| 九色国产91popny在线| 又粗又爽又猛毛片免费看| 欧美黑人巨大hd| 搞女人的毛片| 亚洲七黄色美女视频| 中文资源天堂在线| 在线观看美女被高潮喷水网站 | www.自偷自拍.com| 亚洲人成伊人成综合网2020| 精品人妻1区二区| 日本一区二区免费在线视频| 嫩草影视91久久| 别揉我奶头~嗯~啊~动态视频| 亚洲电影在线观看av| 1024视频免费在线观看| 久久香蕉精品热| 亚洲精品久久国产高清桃花| 亚洲av成人不卡在线观看播放网| 一级作爱视频免费观看| 老熟妇仑乱视频hdxx| 久久性视频一级片| 色哟哟哟哟哟哟| 青草久久国产| 国产精品98久久久久久宅男小说| 欧美成人一区二区免费高清观看 | 免费在线观看视频国产中文字幕亚洲| 久久人人精品亚洲av| 岛国在线免费视频观看| 午夜成年电影在线免费观看| 久热爱精品视频在线9| 国产免费av片在线观看野外av| 制服丝袜大香蕉在线| 久久久国产成人精品二区| 好看av亚洲va欧美ⅴa在| 国产精品影院久久| 淫秽高清视频在线观看| 免费在线观看黄色视频的| 窝窝影院91人妻| 神马国产精品三级电影在线观看 | 国产片内射在线| 777久久人妻少妇嫩草av网站| 精品乱码久久久久久99久播| 三级毛片av免费| 亚洲av五月六月丁香网| 在线观看一区二区三区| 最近最新免费中文字幕在线| 日韩欧美国产在线观看| 老熟妇仑乱视频hdxx| av有码第一页| 中文字幕精品亚洲无线码一区| 在线十欧美十亚洲十日本专区| 一进一出好大好爽视频| 高清毛片免费观看视频网站| 久久伊人香网站| 国产午夜精品久久久久久| 中文字幕熟女人妻在线| 国产单亲对白刺激| 欧美精品亚洲一区二区| 国产私拍福利视频在线观看| 欧美日韩福利视频一区二区| 天堂av国产一区二区熟女人妻 | 无遮挡黄片免费观看| 亚洲欧美一区二区三区黑人| 高清在线国产一区| 一区二区三区高清视频在线| 搡老妇女老女人老熟妇| 九色国产91popny在线| 美女免费视频网站| 麻豆国产av国片精品| 久久久久国产精品人妻aⅴ院| videosex国产| 夜夜躁狠狠躁天天躁| 国产在线观看jvid| 国产精品美女特级片免费视频播放器 | 欧美日韩一级在线毛片| av免费在线观看网站| 久久中文字幕人妻熟女| 国产探花在线观看一区二区| 男女做爰动态图高潮gif福利片| 免费在线观看亚洲国产| 在线观看www视频免费| 欧美zozozo另类| 99国产精品99久久久久| 露出奶头的视频| 91在线观看av| 大型av网站在线播放| av福利片在线观看| 日本一二三区视频观看| 国产精品综合久久久久久久免费| 在线看三级毛片| 成人三级黄色视频| 欧美国产日韩亚洲一区| 日本精品一区二区三区蜜桃| 啦啦啦韩国在线观看视频| 国产三级黄色录像| 一本大道久久a久久精品| 国产成人精品久久二区二区91| 亚洲精品一卡2卡三卡4卡5卡| 亚洲,欧美精品.| 亚洲五月天丁香| 免费在线观看日本一区| 色噜噜av男人的天堂激情| 麻豆av在线久日| 欧美一级a爱片免费观看看 | 欧美黑人巨大hd| 亚洲在线自拍视频| 神马国产精品三级电影在线观看 | 搡老熟女国产l中国老女人| 日韩 欧美 亚洲 中文字幕| 午夜免费激情av| 超碰成人久久| 99在线人妻在线中文字幕| 国产精品永久免费网站| 日韩欧美 国产精品| 欧美日韩亚洲综合一区二区三区_| 99热这里只有精品一区 | 日韩欧美在线二视频| 久久欧美精品欧美久久欧美| 欧美乱妇无乱码| 少妇熟女aⅴ在线视频| 国产精品免费一区二区三区在线| 制服诱惑二区| 搡老熟女国产l中国老女人| 88av欧美| 亚洲欧美精品综合久久99| 午夜福利高清视频| 欧美成人一区二区免费高清观看 | 亚洲欧美精品综合久久99| 我的老师免费观看完整版| 免费看十八禁软件| 亚洲av中文字字幕乱码综合| 国产精品久久久人人做人人爽| 狂野欧美白嫩少妇大欣赏| 国产精品98久久久久久宅男小说| 嫩草影院精品99| 91大片在线观看| av欧美777| 可以免费在线观看a视频的电影网站| 亚洲av成人不卡在线观看播放网| 久9热在线精品视频| 欧美三级亚洲精品| 俺也久久电影网| 麻豆成人av在线观看| 一个人观看的视频www高清免费观看 | 人人妻人人看人人澡| 老汉色av国产亚洲站长工具| 国产av一区在线观看免费| avwww免费| 久久草成人影院| 99国产极品粉嫩在线观看| 国产欧美日韩一区二区精品| 亚洲中文字幕日韩| 可以在线观看的亚洲视频| 国产成人系列免费观看| xxx96com| 99国产综合亚洲精品| 老熟妇乱子伦视频在线观看| 欧美人与性动交α欧美精品济南到| 国产野战对白在线观看| 午夜久久久久精精品| 琪琪午夜伦伦电影理论片6080| 国产精品乱码一区二三区的特点| 国产精华一区二区三区| 精品人妻1区二区| √禁漫天堂资源中文www| 亚洲熟妇熟女久久| 不卡av一区二区三区| 男插女下体视频免费在线播放| 亚洲av成人不卡在线观看播放网| 午夜成年电影在线免费观看| 女生性感内裤真人,穿戴方法视频| 两性午夜刺激爽爽歪歪视频在线观看 | 中文字幕av在线有码专区| 国产成人精品无人区| 欧美日韩黄片免| 欧美丝袜亚洲另类 | 亚洲欧美一区二区三区黑人| 国产午夜福利久久久久久| 99久久精品国产亚洲精品| 99久久精品热视频| 精品高清国产在线一区| a级毛片在线看网站| ponron亚洲| 午夜福利成人在线免费观看| 亚洲精品美女久久av网站| 欧美性长视频在线观看| 两性夫妻黄色片| 久久久国产欧美日韩av| 国产精品一区二区免费欧美| av在线天堂中文字幕| 精品不卡国产一区二区三区| 久久久精品国产亚洲av高清涩受| 草草在线视频免费看| 国产1区2区3区精品| 日韩av在线大香蕉| 午夜福利高清视频| 99热这里只有精品一区 | 亚洲九九香蕉| 一区二区三区激情视频| av片东京热男人的天堂| 在线视频色国产色| 亚洲av电影不卡..在线观看| 亚洲av美国av| 亚洲专区字幕在线| 成年人黄色毛片网站| 女人高潮潮喷娇喘18禁视频| 最新美女视频免费是黄的| 极品教师在线免费播放| 久久久久国产精品人妻aⅴ院| 免费搜索国产男女视频| 亚洲中文字幕日韩| 亚洲一区高清亚洲精品| 亚洲成人国产一区在线观看| 中文字幕久久专区| a级毛片a级免费在线| 岛国在线观看网站| 久99久视频精品免费| 亚洲片人在线观看| 中文字幕高清在线视频| 中国美女看黄片| 精品人妻1区二区| 国产aⅴ精品一区二区三区波| 亚洲九九香蕉| 999久久久精品免费观看国产| 久久草成人影院| 哪里可以看免费的av片| 老熟妇乱子伦视频在线观看| 无人区码免费观看不卡| 免费av毛片视频| 黑人操中国人逼视频| 日韩大码丰满熟妇| 精品久久久久久,| 日韩大尺度精品在线看网址| 欧美在线一区亚洲| 成人国产一区最新在线观看| 精品久久久久久久久久久久久| 成在线人永久免费视频| 精品国产亚洲在线| 色综合欧美亚洲国产小说| 女生性感内裤真人,穿戴方法视频| 国语自产精品视频在线第100页| 中文字幕精品亚洲无线码一区| 精品国产美女av久久久久小说| 女人爽到高潮嗷嗷叫在线视频| 久久九九热精品免费| 美女午夜性视频免费| 丁香六月欧美| 久久精品91无色码中文字幕| 男女午夜视频在线观看| 午夜精品一区二区三区免费看| 大型av网站在线播放| 国产三级中文精品| 久久国产精品人妻蜜桃| 岛国在线免费视频观看| 久久精品人妻少妇| 正在播放国产对白刺激| 日本免费a在线| 午夜视频精品福利| 亚洲第一电影网av| 91av网站免费观看| 午夜视频精品福利| 精品久久久久久久久久久久久| 日韩欧美免费精品| 老熟妇仑乱视频hdxx| 精品久久久久久久久久久久久| 国产亚洲精品久久久久5区| 少妇粗大呻吟视频| 国产片内射在线| 黄频高清免费视频| 亚洲全国av大片| 久久国产精品人妻蜜桃| 99国产精品一区二区蜜桃av|